Graypoint LLC Sells 63 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Graypoint LLC reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,777 shares of the company’s stock after selling 63 shares during the period. Graypoint LLC’s holdings in HCA Healthcare were worth $533,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in HCA. MML Investors Services LLC lifted its stake in shares of HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares during the last quarter. Meritage Group LP purchased a new stake in shares of HCA Healthcare in the third quarter valued at $150,548,000. Alpha DNA Investment Management LLC bought a new position in HCA Healthcare during the 3rd quarter valued at about $869,000. NRI Wealth Management LC bought a new stake in HCA Healthcare in the fourth quarter worth about $2,896,000. Finally, Chiron Investment Management LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $3,548,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on HCA shares. Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Barclays decreased their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Trading Down 2.4 %

Shares of HCA Healthcare stock opened at $303.64 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm’s 50 day simple moving average is $321.66 and its two-hundred day simple moving average is $353.71. HCA Healthcare, Inc. has a 12-month low of $276.50 and a 12-month high of $417.14. The firm has a market capitalization of $76.91 billion, a price-to-earnings ratio of 13.63, a PEG ratio of 1.21 and a beta of 1.64.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Insider Buying and Selling

In related news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.